isosorbide dinitrate has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; He, L; Li, G; Ling, M; Liu, Q; Mai, Z; Sun, R; Wang, X; Xiao, Y; Yang, W; Yu, K; Yu, Z; Zhong, M | 1 |
1 other study(ies) available for isosorbide dinitrate and Ovarian Neoplasms
| Article | Year |
|---|---|
Synergetic delivery of artesunate and isosorbide 5-mononitrate with reduction-sensitive polymer nanoparticles for ovarian cancer chemotherapy.
Topics: Artesunate; Female; Humans; Isosorbide Dinitrate; Nanoparticles; Ovarian Neoplasms; Polymers; Reactive Oxygen Species | 2022 |